BioGaia AB (publ)
BIOG-B
株式のランク
#7843
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
株価
$13.86
最終同期: 2026-10-16
時価総額
$1.37B
変化（1日）
0.65%
変化（1年）
23.21%
国
SE
取引 BioGaia AB (publ) (BIOG-B)
カテゴリー
Healthcare
の時価総額 BioGaia AB (publ)(BIOG-B)
時価総額: $1.37B
October 2026時点で、BioGaia AB (publ) の時価総額は $1.37B です。これは、当社のデータによると、BioGaia AB (publ) が世界で7843rd番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
BioGaia AB (publ) の時価総額の履歴（2015 から 2026 まで）
